Integer (NYSE:ITGR) Coverage Initiated at Citigroup

Equities researchers at Citigroup started coverage on shares of Integer (NYSE:ITGR – Get Rating) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set a “neutral” rating and a $88.00 price target on the medical equipment provider’s stock. Citigroup’s price objective suggests a potential upside of 12.24% from the stock’s current price.

Other equities analysts have also recently issued reports about the stock. KeyCorp upped their price target on shares of Integer from $86.00 to $96.00 in a research report on Friday, April 28th. StockNews.com assumed coverage on shares of Integer in a research report on Thursday, March 16th. They issued a “hold” rating for the company. Bank of America assumed coverage on shares of Integer in a research report on Thursday, March 30th. They issued a “neutral” rating and a $86.00 price target for the company. Piper Sandler initiated coverage on shares of Integer in a research report on Friday, February 24th. They issued an “overweight” rating and a $85.00 price target for the company. Finally, 1-800-FLOWERS.COM reiterated a “maintains” rating on shares of Integer in a research report on Friday, April 28th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Integer presently has an average rating of “Hold” and a consensus target price of $89.00.

Integer Price Performance

Shares of NYSE:ITGR opened at $78.40 on Thursday. The company has a market cap of $2.61 billion, a price-to-earnings ratio of 38.62, a PEG ratio of 1.67 and a beta of 1.14. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.79 and a quick ratio of 1.79. The firm has a 50 day simple moving average of $77.93 and a 200 day simple moving average of $72.99. Integer has a one year low of $50.05 and a one year high of $86.18.

Integer (NYSE:ITGR – Get Rating) last issued its quarterly earnings data on Thursday, April 27th. The medical equipment provider reported $0.87 EPS for the quarter, beating the consensus estimate of $0.82 by $0.05. The business had revenue of $378.79 million during the quarter, compared to the consensus estimate of $352.43 million. Integer had a net margin of 4.71% and a return on equity of 9.54%. The firm’s revenue was up 21.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.78 EPS. Research analysts predict that Integer will post 4.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Integer

A number of large investors have recently bought and sold shares of the stock. BlackRock Inc. grew its holdings in Integer by 0.6% in the first quarter. BlackRock Inc. now owns 6,018,773 shares of the medical equipment provider’s stock worth $484,933,000 after purchasing an additional 38,664 shares during the period. Vanguard Group Inc. grew its holdings in Integer by 1.5% in the third quarter. Vanguard Group Inc. now owns 3,738,440 shares of the medical equipment provider’s stock worth $232,643,000 after purchasing an additional 54,575 shares during the period. Dimensional Fund Advisors LP grew its holdings in Integer by 1.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,146,916 shares of the medical equipment provider’s stock worth $166,383,000 after purchasing an additional 30,583 shares during the period. Victory Capital Management Inc. grew its holdings in Integer by 23.2% in the first quarter. Victory Capital Management Inc. now owns 1,422,398 shares of the medical equipment provider’s stock worth $110,236,000 after purchasing an additional 267,565 shares during the period. Finally, State Street Corp grew its holdings in Integer by 2.5% in the third quarter. State Street Corp now owns 1,298,343 shares of the medical equipment provider’s stock worth $80,796,000 after purchasing an additional 31,953 shares during the period. 98.42% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

(Get Rating)

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies.